Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How do you approach an AVL (atypical vascular lesion) of the breast?
Answer from: Radiation Oncologist at Community Practice
I would favor excision (presuming post EBRT) as there is some suggestion that they can transform to angiosarcoma.
Sign In
or
Register
to read more
3916
Related Questions
Is it appropriate to use bolus with hypofractionated PMRT?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
When do you start adjuvant radiation with areas of delayed wound healing after reduction mammoplasty?
Does pre-chemotherapy extent of nodal involvement impact your decision to offer adjuvant radiation in cN1, ypN0 triple-negative breast cancer?
Does a high genomic risk score impact your radiation fields for patients with breast cancer?
Is re-excision of residual disease ever itself an indication for PMRT?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
Would you feel comfortable doing high tangents with ultra-hypofractionation?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
How do you weigh upfront nodal burden when deciding to omit PMRT in a patient with cN1, ypN0 disease after neoadjuvant chemo, mastectomy and ALND?